http://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Submit Abstract Slidegk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Science Advisor Slidegk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Amy Chang Bannergk-is-651.jpglink
http://www.asm.org/modules/mod_image_show_gk4/cache/Governance Hero Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
10-12-2016mSphere Direct
10-12-2016Science Advisor
10-12-2016Amy Chang
10-12-2016Nominate
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreat Meeting
REGISTER

 

Camilli_AndrewAndrew Camilli investigates the mechanisms of pathogenesis and transmission of mucosal pathogens. The main goal of his laboratory is to increase understanding of the virulence properties of mucosal pathogens using Vibrio cholerae and Streptococcus pneumoniae as model organisms, and secondly to develop new types of vaccines for these two pathogens.  V. cholerae is a motile bacterium that maintains a substantial environmental reservoir, and causes endemic and epidemic cholera in many underdeveloped nations.  In contrast, the bacterium S. pneumoniae is a strict human commensal and pathogen and is a major cause of pneumonia, meningitis, bacteremia and otitis media throughout the world.  His primary research focus is identifying V. cholerae and S. pneumoniae genes and their protein products that are expressed during the infection process and during transmission, and then elucidating their regulation and function.  He has chosen this focus because bacteria generally express genes only when and where needed and thus do not readily reveal their pathogenic armament outside of infected tissues, and secondly because detailed knowledge of the behavior of pathogens and the antigens they express during infection can aid the development of more effective vaccines, antimicrobials and diagnostics.

TPL_asm2013_SEARCH

91006